Carbetocin versus oxytocin for the prevention of post-partum hemorrhage in caesarean section

ISRCTN ISRCTN69805695
DOI https://doi.org/10.1186/ISRCTN69805695
Secondary identifying numbers SSMCH201476
Submission date
10/03/2016
Registration date
20/04/2016
Last edited
13/04/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
A caesarean section is an operation to deliver a baby. There is a risk of heavy bleeding after caesarean section, known as postpartum haemorrhage (PPH). The aim of this study is to evaluate the effectiveness and safety of the drug carbetocin in comparison to oxytocin at preventing PPH in the third stage of labour (when the placenta is delivered) after caesarean section.

Who can participate?
Women with a single pregnancy undergoing cesarean delivery at term

What does the study involve?
Participants are randomly allocated to be treated with either intravenous (into a vein) carbetocin or intramuscular (into a muscle) oxytocin in the third stage of labour. The amount of blood lost, the need for additional drugs and blood transfusions, and adverse effects are recorded in both groups.

What are the possible benefits and risks of participating?
The possible benefit is control of bleeding after cesarean section, which could otherwise lead to postpartum hemorrhage with fatal outcome. There is a small risk of minor side effects.

Where is the study run from?
Sir Salimullah Medical College and Mitford Hospital (Bangladesh)

When is the study starting and how long is it expected to run for?
January to December 2015

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
1. Prof Ferdousi Begum
2. Dr Shakila Yesmin

Contact information

Prof Ferdousi Begum
Scientific

Popular Diagnostic centre
Shyamoli
Dhaka
-
Bangladesh

ORCiD logoORCID ID 0000-0002-4087-1818
Dr Shakila Yesmin
Scientific

Department of Obstetrics and Gynecology
Sir Salimullah Medical College and Mitford Hospital
Dhaka
-
Bangladesh

Study information

Study designSingle-centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCarbetocin versus oxytocin for the prevention of post-partum hemorrhage in caesarean section: a randomised controlled trial
Study objectivesCarbetocin is more effective than oxytocin in the active management of third stage of labour.
Ethics approval(s)Institutional Ethics Committee of Sir Salimullah Medical College, Dhaka, Bangladesh, 22/12/2014, Ref no- SSMC /2014/76
Health condition(s) or problem(s) studiedThird stage of labour
Intervention64 pregnant women who had undergone cesarean delivery were randomized into two groups. One group of patients received intravenous 100 microgram carbetocin and another group of patients received intramuscular 10 IU oxytocin in the third stage of labour.
Intervention typeDrug
Pharmaceutical study type(s)
PhasePhase IV
Drug / device / biological / vaccine name(s)Carbetocin, oxytocin
Primary outcome measureEfficacy of carbetocin over oxytocin for the management of third stage of labor
Secondary outcome measures1. The need for additional uterotonic within 24 hours of delivery after carbetocin or oxytocin administration
2. The amount of blood loss in 24 hours after delivery after carbetocin or oxytocin administration
3. The need for blood transfusion during the first 24 hours after delivery after carbetocin or oxytocin administration
4. The adverse effects of carbetocin and oxytocin after administration
Overall study start date01/01/2015
Completion date01/12/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants64
Key inclusion criteriaWomen with a single pregnancy undergoing cesarean delivery at term
Key exclusion criteria1. Placenta praevia
2. Multiple gestations
3. Placental abruption
4. Hypertensive disorders in pregnancy
5. Preeclampsia
6. Cardiac, renal or liver diseases
7. Epilepsy
8. Women with history of hypersensitivity to carbetocin according to the Br National Formulary
Date of first enrolment01/01/2015
Date of final enrolment01/12/2015

Locations

Countries of recruitment

  • Bangladesh

Study participating centre

Sir Salimullah Medical College and Mitford Hospital
Dhaka
-
Bangladesh

Sponsor information

Beacon Pharmaceuticals Ltd (Bangladesh)
Industry

153-154 Tejgaon I/A
Dhaka-1208
Dhaka
-
Bangladesh

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planNext issue of FIGO journal
IPD sharing plan